Literature DB >> 22418867

Role and regulation of STAT3 phosphorylation at Ser727 in melanocytes and melanoma cells.

Masanobu Sakaguchi1, Masahiro Oka, Tetsushi Iwasaki, Yasuo Fukami, Chikako Nishigori.   

Abstract

The transcription factor signal transducer and activator of transcription 3 (STAT3) has two important phosphorylation sites, Tyr705 and Ser727, for its activation. Ser727 phosphorylation has been considered to be a secondary event after Tyr705 phosphorylation. In this study, the role and regulation of Ser727 phosphorylation in STAT3 in melanocytic cells were examined. STAT3 was phosphorylated on Ser727 in the absence of Tyr705 phosphorylation in melanocytes. 12-O-tetradecanoylphorbol-13-acetate-induced increase in cell survival activity and nuclear translocation of STAT3 was associated with Ser727 phosphorylation. Ser727 was constitutively phosphorylated in all melanoma cell lines examined irrespective of Tyr705 phosphorylation. The possible involvement of Ser727 phosphorylation in STAT3 in cell survival activity and nuclear translocation of STAT3 in melanocytes was demonstrated also in melanoma cells. The constitutive Ser727 phosphorylation in melanoma cells was partially mediated by the B-Raf-MEK-ERK1/2 pathway. Immunohistochemical studies on specimens of primary lesions of acral lentiginous melanoma revealed that Ser727 phosphorylation precedes Tyr705 phosphorylation in the early stages of melanoma progression. Our results indicate that Ser727 phosphorylation on STAT3 is not necessarily a secondary event after Tyr705 phosphorylation and suggest that it has a role in the regulation of cell survival activity and nuclear translocation of STAT3 in melanocytic cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22418867     DOI: 10.1038/jid.2012.45

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  41 in total

1.  Targeting multiple key signaling pathways in melanoma using leelamine.

Authors:  Raghavendra Gowda; SubbaRao V Madhunapantula; Omer F Kuzu; Arati Sharma; Gavin P Robertson
Journal:  Mol Cancer Ther       Date:  2014-03-31       Impact factor: 6.261

2.  Disruption of mammalian target of rapamycin complex 1 in macrophages decreases chemokine gene expression and atherosclerosis.

Authors:  Ding Ai; Hongfeng Jiang; Marit Westerterp; Andrew J Murphy; Mi Wang; Anjali Ganda; Sandra Abramowicz; Carrie Welch; Felicidad Almazan; Yi Zhu; Yury I Miller; Alan R Tall
Journal:  Circ Res       Date:  2014-03-31       Impact factor: 17.367

3.  Interleukin-20 receptor expression in the trabecular meshwork and its implication in glaucoma.

Authors:  Kate E Keller; Yong-Feng Yang; Ying Ying Sun; Renee Sykes; Natalie Donna Gaudette; John R Samples; Ted S Acott; Mary K Wirtz
Journal:  J Ocul Pharmacol Ther       Date:  2014-01-23       Impact factor: 2.671

4.  CD36 Enhances Vascular Smooth Muscle Cell Proliferation and Development of Neointimal Hyperplasia.

Authors:  Hong Yue; Maria Febbraio; Philip A Klenotic; David J Kennedy; Yueheng Wu; Shaoxian Chen; Amira F Gohara; Oliver Li; Adam Belcher; Bin Kuang; Thomas M McIntyre; Roy L Silverstein; Wei Li
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-02       Impact factor: 8.311

5.  Novel Paracrine Functions of Smooth Muscle Cells in Supporting Endothelial Regeneration Following Arterial Injury.

Authors:  Jun Ren; Ting Zhou; Vijaya Satish Sekhar Pilli; Noel Phan; Qiwei Wang; Kartik Gupta; Zhenjie Liu; Nader Sheibani; Bo Liu
Journal:  Circ Res       Date:  2019-04-12       Impact factor: 17.367

6.  The competitive nature of signal transducer and activator of transcription complex formation drives phenotype switching of T cells.

Authors:  Ildar I Sadreev; Michael Z Q Chen; Yoshinori Umezawa; Vadim N Biktashev; Claudia Kemper; Diana V Salakhieva; Gavin I Welsh; Nikolay V Kotov
Journal:  Immunology       Date:  2017-11-22       Impact factor: 7.397

7.  JNK1/2 expression and modulation of STAT3 signaling in oral cancer.

Authors:  Ioannis Gkouveris; Nikolaos Nikitakis; Maria Karanikou; George Rassidakis; Alexandra Sklavounou
Journal:  Oncol Lett       Date:  2016-05-24       Impact factor: 2.967

8.  Activation of the FGFR-STAT3 pathway in breast cancer cells induces a hyaluronan-rich microenvironment that licenses tumor formation.

Authors:  Laura R Bohrer; Pavlina Chuntova; Lindsey K Bade; Thomas C Beadnell; Ronald P Leon; Nicholas J Brady; Yungil Ryu; Jodi E Goldberg; Stephen C Schmechel; Joseph S Koopmeiners; James B McCarthy; Kathryn L Schwertfeger
Journal:  Cancer Res       Date:  2013-11-06       Impact factor: 12.701

9.  Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitor.

Authors:  Brent J Tierney; Georgia A McCann; Shan Naidu; Kellie S Rath; Uksha Saini; Ross Wanner; Periannan Kuppusamy; Adrian Suarez; Paul J Goodfellow; David E Cohn; Karuppaiyah Selvendiran
Journal:  Gynecol Oncol       Date:  2014-07-16       Impact factor: 5.482

10.  STAT3 serine 727 phosphorylation influences clinical outcome in glioblastoma.

Authors:  Guo-Shi Lin; Yu-Peng Chen; Zhi-Xiong Lin; Xing-Fu Wang; Zong-Qing Zheng; Long Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.